Latest Market Expansion News

PointsBet’s FY26 nine-month report reflects a transitional period marked by MIXI’s 66.4% takeover, a slight revenue dip to AUD 186.6 million, and a near breakeven normalised EBITDA. Australian revenue softened by 4%, while Canada grew 13% driven by iGaming momentum.

ClearVue Technologies has boosted its capital raising to $6.25 million, with significant board participation and revised loan terms, while its Gen 3 Vision Glass secures crucial EN 1279-5 certification.

CleanSpace's AGILE respirator has achieved AS/NZS 17420.2:2021 certification, paving the way for commercialisation in Australia and New Zealand alongside its recent European approval.

IODM Limited has broadened its revenue share agreement with TransferMate, now covering UK and European universities, aiming to deepen its presence in the higher education payments sector.

SciDev Ltd has completed a strategic review addressing past underperformance and is refocusing on an integrated water solutions platform targeting core markets. The company confirmed FY26 guidance with revenue of $82 to $87 million and underlying EBITDA of approximately $4 million, while maintaining a sound balance sheet.

Stealth Group Holdings has posted record preliminary FY26 results, driven by strong organic growth and the transformative acquisition of Hardware & Building Traders (HBT). The company remains on track for its ambitious FY28 sales and EBITDA margin targets.

Memphasys has locked in a 12-month exclusive supply agreement with Monash IVF for its Felix™ sperm selection system, marking its biggest commercial contract to date and setting a foundation for recurring revenue.

InteliCare (ASX:ICR) is hitting a commercial inflection point, backed by a landmark $8.8 million contract with mecwacare and a growing pipeline across aged care sectors. Its AI-powered platform promises measurable improvements in care outcomes and operational efficiency.

Hazer Group has locked in a binding MOU with South Australia's Hallett Group to integrate its graphite into low-emissions concrete, reinforcing its regional decarbonisation foothold.

Vitrafy Life Sciences has secured A$30 million through an institutional placement to ramp up manufacturing of its Guardion cryopreservation devices and expand US sales operations, with an additional A$2 million sought via a shareholder plan.

TruScreen has secured clinical validation from the world’s largest cervical screening study in China, setting the stage for rapid market expansion across Asia, Africa, and Europe.

CleanSpace Holdings has achieved a major regulatory milestone with European EN 12941 certification for its new AGILE loose-fitting PAPR, positioning the company for growth in its largest market and preparing for imminent Australian approval.